首页> 美国卫生研究院文献>Indian Heart Journal >Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study

【2h】

Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study

机译：Sacubitril / Valsartan的疗效和安全性与慢性心力衰竭患者患者的肌综合作用降低射血分数：ParAdigm-HF印度的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To determine efficacy and safety of sacubitril/valsartan compared with enalapril in Indian patients of PARADIGM-HF trial.

机译：与印度范式临时患者患者的CATUBITRIL / VALSARTANT的疗效和安全性。

著录项

期刊名称 Indian Heart Journal
作者
Anil Ranjeetmal Jain; Rakesh Kumar Aggarwal; Nanyam Srinivas Rao; Gauri Billa; Shankar Kumar;
展开▼
作者单位

展开▼
年(卷),期 2020(72),6
年度 2020
页码 535–540
总页数 6
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
All-cause mortality; Cardiovascular death; HF hospitalization; Indian;

机译：全因死亡率;心血管死亡;HF住院;印度人;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study [J] . Anil Ranjeetmal Jain, Rakesh Kumar Aggarwal, Nanyam Srinivas Rao, Indian heart journal . 2020,第6期

机译：Sacubitril / Valsartan的疗效和安全性与慢性心力衰竭患者患者的肌综合作用，降低射血分数：ParAdigm-HF印度的结果
2. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF [J] . Bohm Michael, Young Robin, Jhund Pardeep S., European Heart Journal: The Journal of the European Society of Cardiology . 2017,第15期

机译：慢性心力衰竭患者的Sacubitril / Valsartan（LCZ696）的收缩压，心血管结果和疗效和安全性，降低射血分数：ParAdigm-HF的结果
3. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial [J] . Vardeny Orly, Claggett Brian, Packer Milton, European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2016,第10期

机译：沙比特利/缬沙坦与依那普利在心力衰竭且射血分数降低时低于目标剂量的疗效：PARADIGM-HF试验
4. Effects of optimized heart failure medication on central sleep apnea with Cheyne-Stokes respiration pattern in chronic heart failure with reduced left-ventricular ejection fraction [C] . C Schoebel, I Fietze, T Penzel Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2019

机译：优化的心力衰竭药物对慢性心力衰竭左心室射血分数降低的Cheyne-Stokes呼吸模式对中枢性睡眠呼吸暂停的影响
5. Efficacy of Sacubitril/Valsartan in the Treatment of Women with Heart Failure with Preserved Ejection Fraction [D] . Lee, Rita Joyce. 2020

机译：Sacubitril / Valsartan在患有射血分数的心力衰竭治疗妇女的疗效
6. Systolic blood pressure cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF [O] . Michael Böhm, Robin Young, Pardeep S. Jhund, -1

机译：慢性心力衰竭和射血分数降低的患者的收缩压心血管预后以及沙必比/缬沙坦（LCZ696）的疗效和安全性：PARADIGM-HF的结果
7. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF [O] . Böhm, Michael, Young, Robin, Jhund, Pardeep, 2017

机译：收缩压，心血管结局以及sacubitril / valsartan（LCZ696）在慢性心力衰竭和射血分数降低患者中的疗效和安全性：paRaDIGm-HF的结果

Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study

摘要

著录项

相似文献

相关主题

期刊订阅